Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Coagulation system Stories

2013-07-04 12:21:48

DUBLIN, July 4, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wrjhsx/coagulation) has announced the addition of the "Coagulation Diagnostic Testing Markets" [http://www.researchandmarkets.com/research/wrjhsx/coagulation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Coagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the...

2013-07-03 12:23:55

Recombinant albumin fusion platform forms basis of innovation AMSTERDAM, July 3, 2013 /PRNewswire/ -- CSL Behring today presented Phase I data of their recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) in healthy volunteers at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam. (Logo: http://photos.prnewswire.com/prnh/20130627/NY39350LOGO ) CSL Behring, in collaboration with its parent company, CSL Limited (ASX:...

2013-07-03 12:23:53

Recombinant albumin fusion platform forms basis of innovation AMSTERDAM, July 3, 2013 /PRNewswire/ -- CSL Behring today presented a population pharmacokinetic model for recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam. The model confirms earlier results from the first-in-human dose escalation trial, which demonstrated improved pharmacokinetics of rIX-FP, with...

Tick Saliva New Insight Into Blood Clotting
2013-07-03 09:21:15

Rebekah Eliason for redOrbit.com - Your Universe Online Scientists recently uncovered a surprising potential connection between tick saliva and treatment for heart disease and stroke. Ixodes ticks, commonly known as deer ticks or blacklegged ticks, contain a specific protein in their spit that links to treatment for these diseases. These ticks have also long been known as transmitters of a variety of diseases, including Lyme disease. Deer ticks burrow into the skin of their host and...

2013-07-03 08:25:12

Results of Phase I/II PROLONG-9FP trial program also demonstrate efficacy in treatment of bleeding episodes and improved pharmacokinetics of rIX-FP compared to current treatment options; recombinant albumin fusion platform forms basis of innovation AMSTERDAM, July 3, 2013 /PRNewswire/ -- Data presented by CSL Behring today showed clinical efficacy of a once-weekly dosing regimen of recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP). Results of the study...

2013-07-03 08:24:34

--New Data Show a Simple Subcutaneous Injection of Factor VIIa-CTP Could Potentially Replace Current Therapies Administered Via Infusion-- AMSTERDAM and NES-ZIONA, Israel, July 3, 2013 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE MKT: PBTH), today announced that the company will present new results from preclinical studies of its long-acting clotting factor VIIa (Factor VIIa-CTP), a next-generation investigational therapy in advanced preclinical development for the potential treatment...

2013-07-02 12:29:48

Pharmacokinetic results indicate rVIII-SingleChain may have advantages over multi-chain rFVIII AMSTERDAM, July 2, 2013 /PRNewswire/ -- CSL Behring today announced that pharmacokinetic results for its novel investigational recombinant coagulation single-chain factor VIII (rVIII-SingleChain) showed improved half-life over octocog alfa (the comparator). It also demonstrated a safety and efficacy profile that supports advancement to late-stage clinical development. The data were...

2013-07-01 23:03:49

Research report “Recombinant Coagulation Factors 2013 - The Race to Market and for Market Shares: A Technology & Pipeline Assessment and Corporate Benchmarking Analysis” prepared by La Merie Publishing has been recently published by Market Publishers Ltd. London, UK (PRWEB) July 01, 2013 In 2012, combined product sales of 3 classes of recombinant coagulation factors utilized in hemophilia were estimated at above USD 7.1 million. Currently, the new recombinant coagulation factors...

2013-06-27 23:52:49

Rockville, MD | 6/26/2013 | PRWeb – MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: New Oral Anticoagulants Markets http://www.marketresearch.com/land/product.asp?productid=7458266&progid=85535 (PRWEB) June 26, 2013 New Oral Anticoagulants Markets TriMarkPublications.com cites in its newly published “New Oral Anticoagulants Markets” report that the global anticoagulants market will spike to over $24 billion...

2013-06-27 23:29:59

Conquer Low Platelets created by Louis Cruz is a new book that teaches people how to increase platelets by using proven and natural remedies. In a full Conquer Low Platelets overview, Tony Nguyen from the site Vkool.com indicates if the book is worth buying. Seattle, Wa (PRWEB) June 27, 2013 Conquer Low Platelets created by Louis Cruz is a new book that teaches people how to increase platelets naturally and quickly by using natural remedies. This book also instructs people how to avoid...